The results are from an 18-month study designed to see whether statin therapy could slow the progression of multiple sclerosis.
cytoplasmic antibodies can achieve high rates of remission, but with the
risk of serious toxic effects. the results of a placebo-controlled trial in
patients with severe disease suggest that an effective alternative could
be on the horizon.
New Research and New Approaches Offer Hope to Families Coping With Food Allergies
By LISA STARK
Three-year-old Peyton Youse of Charlotte, N.C., is severely allergic to peanuts.
But now doctors are fighting back -- with peanuts.
Original article at BioWorld Today
By Karen Pihl-Carey
Senior Staff Writer, BioWorld Today
In the early part of the 20th century, before the Depression and World War II, dozens of children lay comatose in hospital wards where hopeless families gathered awaiting their inevitable deaths.
The treatment involved weakening the patient's immune system, then giving the recipient bone marrow from the person who donated the organ. In one experiment, four of five kidney recipients were off immune-suppressing medicines up to five years later.
LOS ANGELES (AP) - In what's being called a major advance in organ transplants, doctors say they have developed a technique that could free many patients from having to take anti-rejection drugs for the rest of their lives.
Dr. David H. Sachs was full of optimism when the third patient in his $1 million study was wheeled into the recovery room at Massachusetts General Hospital after an experimental kidney transplant.
The first two patients had thrived, adding credibility to an unorthodox idea that Sachs had pioneered over his career, that transplanting a donor's bone marrow along with the kidney could solve the problem of organ rejection, sparing patients a lifetime of powerful antirejection drugs.